Adipose tissue specific CCL18 associates with cardiometabolic diseases in non-obese individuals implicating CD4+ T cells

[1]  Patrik L. Ståhl,et al.  An integrated single cell and spatial transcriptomic map of human white adipose tissue , 2023, Nature Communications.

[2]  C. Lian,et al.  T cell-attracting CCL18 chemokine is a dominant rejection signal during limb transplantation , 2022, Cell reports. Medicine.

[3]  G. Frühbeck,et al.  Increased Levels of Interleukin-36 in Obesity and Type 2 Diabetes Fuel Adipose Tissue Inflammation by Inducing Its Own Expression and Release by Adipocytes and Macrophages , 2022, Frontiers in Immunology.

[4]  Y. Taniyama,et al.  The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples , 2022, Frontiers in Endocrinology.

[5]  T. Lüscher,et al.  Inflammation in Metabolic Cardiomyopathy , 2021, Frontiers in Cardiovascular Medicine.

[6]  F. Takeda,et al.  Risk factors for multiple metabolic syndrome components in obese and non-obese Japanese individuals. , 2021, Preventive medicine.

[7]  A. Carpentier,et al.  Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations , 2021, Endocrine reviews.

[8]  B. Czerniecki,et al.  Differentiation and Regulation of TH Cells: A Balancing Act for Cancer Immunotherapy , 2021, Frontiers in Immunology.

[9]  F. Al-Mulla,et al.  Elevated adipose tissue associated IL-2 expression in obesity correlates with metabolic inflammation and insulin resistance , 2020, Scientific Reports.

[10]  S. Meri,et al.  The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System , 2020, Frontiers in Immunology.

[11]  Sarah E. Jackson,et al.  The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People , 2020, Frontiers in Cellular and Infection Microbiology.

[12]  P. Arner,et al.  Long‐term changes in adipose tissue gene expression following bariatric surgery , 2020, Journal of internal medicine.

[13]  T. Shirasawa,et al.  Associations between normal weight central obesity and cardiovascular disease risk factors in Japanese middle-aged adults: a cross-sectional study , 2019, Journal of Health, Population and Nutrition.

[14]  M. McCarthy,et al.  Homogeneity in the association of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study , 2019, PLoS medicine.

[15]  P. Arner,et al.  Insulin action is severely impaired in adipocytes of apparently healthy overweight and obese subjects , 2019, Journal of internal medicine.

[16]  Lulu Chen,et al.  Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies , 2019, Cardiovascular Diabetology.

[17]  P. Haslett,et al.  Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load , 2019, Scientific Reports.

[18]  Dimitris Tousoulis,et al.  The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives , 2018, European cardiology.

[19]  D. Agrawal,et al.  Adipokine Dysregulation and Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae? , 2019, Journal of Cardiovascular Translational Research.

[20]  M. Kratz,et al.  Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. , 2018, Comprehensive Physiology.

[21]  Anastasia V Aladinskaya,et al.  Tumor Necrosis Factor-α and C-C Motif Chemokine Ligand 18 Associate with Atherosclerotic Lipid Accumulation In situ and In vitro. , 2018, Current pharmaceutical design.

[22]  Huaizhu Wu,et al.  T Cells in Adipose Tissue: Critical Players in Immunometabolism , 2018, Front. Immunol..

[23]  D. Diamond,et al.  LDL-C Does Not Cause Cardiovascular Disease: a comprehensive review of current literature , 2018 .

[24]  H. Nafakhi,et al.  ECG markers of arrythmogenic risk relationships with pericardial fat volume and BMI in patients with coronary atherosclerosis. , 2018, Journal of electrocardiology.

[25]  Mi-Jeong Lee.  Transforming growth factor beta superfamily regulation of adipose tissue biology in obesity. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[26]  S. Joost,et al.  Single cell transcriptomics suggest that human adipocyte progenitor cells constitute a homogeneous cell population , 2017, Stem Cell Research & Therapy.

[27]  P. Arner,et al.  Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[28]  P. Arner,et al.  Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism , 2017, Journal of internal medicine.

[29]  J. Lieberman,et al.  Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer , 2017, Cell Research.

[30]  P. Arner,et al.  Long-term Protective Changes in Adipose Tissue After Gastric Bypass , 2016, Diabetes Care.

[31]  H. Crijns,et al.  CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular events , 2016, Netherlands Heart Journal.

[32]  D. Rajpal,et al.  The epigenetic signature of systemic insulin resistance in obese women , 2016, Diabetologia.

[33]  P. Arner,et al.  Adipose and Circulating CCL18 Levels Associate With Metabolic Risk Factors in Women. , 2016, The Journal of clinical endocrinology and metabolism.

[34]  D. Langin,et al.  Adipocyte lipolysis and insulin resistance. , 2016, Biochimie.

[35]  S. Mandrup,et al.  Effects of selected bioactive food compounds on human white adipocyte function , 2016, Nutrition & Metabolism.

[36]  P. Arner,et al.  Increased fat cell size: a major phenotype of subcutaneous white adipose tissue in non-obese individuals with type 2 diabetes , 2016, Diabetologia.

[37]  I. Gonçalves,et al.  Circulating cytokines reflect the expression of pro-inflammatory cytokines in atherosclerotic plaques. , 2015, Atherosclerosis.

[38]  P. Arner,et al.  MAFB as a novel regulator of human adipose tissue inflammation , 2015, Diabetologia.

[39]  S. Masoodi,et al.  Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. , 2015, World journal of diabetes.

[40]  K. Lalić,et al.  Relationship between Obesity, Adipocytokines and Inflammatory Markers in Type 2 Diabetes: Relevance for Cardiovascular Risk Prevention , 2014, International journal of environmental research and public health.

[41]  P. Arner,et al.  Allograft inflammatory factor 1 (AIF-1) is a new human adipokine involved in adipose inflammation in obese women , 2013, BMC Endocrine Disorders.

[42]  A. Garin,et al.  The Activity of CCL18 is Principally Mediated through Interaction with Glycosaminoglycans , 2013, Front. Immunol..

[43]  Piotr J. Balwierz,et al.  Adipose Tissue MicroRNAs as Regulators of CCL2 Production in Human Obesity , 2012, Diabetes.

[44]  Ming Zhao,et al.  The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum , 2012, Immunology.

[45]  I. Luzina,et al.  CCR6 is not necessary for functional effects of human CCL18 in a mouse model , 2012, Fibrogenesis & tissue repair.

[46]  S. Haffner,et al.  Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. , 2012, The Journal of clinical endocrinology and metabolism.

[47]  P. O S I T I O N S T A T E M E N T.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[48]  S. Duong-Quy,et al.  Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis , 2011, European Respiratory Journal.

[49]  A. Tedgui,et al.  Recent Advances on the Role of Cytokines in Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[50]  M. Ewen,et al.  CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. , 2011, Cancer cell.

[51]  B. Wallaert,et al.  The chemokine CCL18 generates adaptive regulatory T cells from memory CD4+ T cells of healthy but not allergic subjects. , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  E. Arner,et al.  Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity , 2010, Diabetologia.

[53]  E. Arner,et al.  Tumor necrosis factor alpha and regulation of adipose tissue. , 2010, The New England journal of medicine.

[54]  J. Danesh,et al.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.

[55]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[56]  G. Moneta,et al.  Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .

[57]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[58]  B. Fagerberg,et al.  Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques. , 2009, Atherosclerosis.

[59]  M. Olschewski,et al.  Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[60]  K. Narayan,et al.  Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.

[61]  M. Czech,et al.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[62]  J. Ordovás,et al.  Atherogenecity of LDL and Unfavorable Adipokine Profile in Metabolically Obese, Normal‐weight Woman , 2008, Obesity.

[63]  K. Clément,et al.  Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity , 2008, Genome Biology.

[64]  H. Putter,et al.  CC Chemokine Ligand-5 (CCL5/RANTES) and CC Chemokine Ligand-18 (CCL18/PARC) Are Specific Markers of Refractory Unstable Angina Pectoris and Are Transiently Raised During Severe Ischemic Symptoms , 2007, Circulation.

[65]  A. Prasse,et al.  CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. , 2007, Arthritis and rheumatism.

[66]  J. Danesh,et al.  Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies , 2007, Circulation.

[67]  Y. Wan,et al.  Regulatory T cells, transforming growth factor-beta, and immune suppression. , 2007, Proceedings of the American Thoracic Society.

[68]  B. W. Schreurs,et al.  Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, Toll-like receptors and rheumatoid synovial fluid , 2006, BMC Immunology.

[69]  P. Arner,et al.  Prospective and controlled studies of the actions of insulin and catecholamine in fat cells of obese women following weight reduction , 2005, Diabetologia.

[70]  J. Van Damme,et al.  Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes , 2005, Journal of leukocyte biology.

[71]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[72]  J. Pankow,et al.  Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.

[73]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[74]  Ralph B D'Agostino,et al.  Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. , 2002, Archives of internal medicine.

[75]  P. Arner.  Insulin resistance in type 2 diabetes: role of fatty acids , 2002, Diabetes/metabolism research and reviews.

[76]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[77]  J. Ragnaud,et al.  Th1 (IL‐2, interferon‐gamma (IFN‐γ)) and Th2 (IL‐10, IL‐4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE) , 1999, Clinical and experimental immunology.

[78]  T. Mcclanahan,et al.  A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.

[79]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[80]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[81]  W. Fiers,et al.  Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. , 1992, Endocrinology.

[82]  P. Bennett,et al.  SEQUENTIAL CHANGES IN SERUM INSULIN CONCENTRATION DURING DEVELOPMENT OF NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[83]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[84]  J. Hirsch,et al.  The role of adipose cell size and adipose tissue insulin sensitivity in the carbohydrate intolerance of human obesity. , 1968, The Journal of clinical investigation.

[85]  R. Sharma,et al.  Serum Cholesterol and Atherosclerosis in Man , 1961, Circulation.